Modeling within-host dynamics of influenza virus infection including immune responses.
Abstract: Influenza virus infection remains a public health problem worldwide. The mechanisms underlying viral control during an uncomplicated influenza virus infection are not fully understood. Here, we developed a mathematical model including both innate and adaptive immune responses to study the within-host dynamics of equine influenza virus infection in horses. By comparing modeling predictions with both interferon and viral kinetic data, we examined the relative roles of target cell availability, and innate and adaptive immune responses in controlling the virus. Our results show that the rapid and substantial viral decline (about 2 to 4 logs within 1 day) after the peak can be explained by the killing of infected cells mediated by interferon activated cells, such as natural killer cells, during the innate immune response. After the viral load declines to a lower level, the loss of interferon-induced antiviral effect and an increased availability of target cells due to loss of the antiviral state can explain the observed short phase of viral plateau in which the viral level remains unchanged or even experiences a minor second peak in some animals. An adaptive immune response is needed in our model to explain the eventual viral clearance. This study provides a quantitative understanding of the biological factors that can explain the viral and interferon kinetics during a typical influenza virus infection.
Publication Date: 2012-06-28 PubMed ID: 22761567PubMed Central: PMC3386161DOI: 10.1371/journal.pcbi.1002588Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- N.I.H.
- Extramural
- Research Support
- Non-U.S. Gov't
- Research Support
- U.S. Gov't
- Non-P.H.S.
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research article is about the development and application of a mathematical model to better understand the dynamics of an influenza virus infection within a host, with a focus on both innate and adaptive immune responses.
Development of the Mathematical Model
- The researchers created a mathematical model to study how equine influenza virus infection works within horses, with a particular focus on both innate and adaptive immune responses.
- This model is designed to help gain a deeper understanding of the mechanisms underlying how a host controls an uncomplicated influenza virus infection.
Utilization of the Mathematical Model
- The model was compared with data from both interferon and viral kinetics to examine how several factors, including target cell availability and both kinds of immune responses, play a role in the control of the virus.
- The results of the model show that the significant reduction of viral load observed (2 to 4 logs within a day) after its peak could be explained by infected cells being killed by interferon-activated cells, such as natural killer cells.
- This phase corresponds to the role of the innate immune response, eradicating the infected cells quickly and effectively.
Understanding Different Phases of Infection
- Once the viral load declines to a lower level, the post peak phase of infection is characterized by a loss of the antiviral effect induced by interferon and an increased availability of target cells resulting from the loss of the antiviral state.
- This explains the brief phase in which viral level plateaus, remaining unchanged or even experiencing a secondary minor peak in some cases.
The Role of Adaptive Immune Response
- The model further indicates that for eventual viral clearance to happen, an adaptive immune response is necessary.
- This suggests that the body’s ability to create specific antibodies to the virus strain is crucial to completely get rid of the virus.
Conclusion
- In conclusion, this study provides quantifiable insight into the complex interactions between the influenza virus, the host, and the host’s immune response.
- It aids in the understanding of why and how certain phases of the disease progress as they do and reveals the very different roles of innate and adaptive immune responses play in combating a common influenza virus infection.
Cite This Article
APA
Pawelek KA, Huynh GT, Quinlivan M, Cullinane A, Rong L, Perelson AS.
(2012).
Modeling within-host dynamics of influenza virus infection including immune responses.
PLoS Comput Biol, 8(6), e1002588.
https://doi.org/10.1371/journal.pcbi.1002588 Publication
Researcher Affiliations
- Department of Mathematics and Statistics, Oakland University, Rochester, Michigan, United States of America.
MeSH Terms
- Adaptive Immunity
- Animals
- Computational Biology
- Computer Simulation
- Horse Diseases / immunology
- Horse Diseases / virology
- Horses
- Host-Pathogen Interactions / immunology
- Humans
- Immunity, Innate
- Influenza A Virus, H3N8 Subtype / immunology
- Influenza A Virus, H3N8 Subtype / pathogenicity
- Influenza, Human / immunology
- Influenza, Human / virology
- Models, Immunological
- Orthomyxoviridae Infections / immunology
- Orthomyxoviridae Infections / veterinary
- Orthomyxoviridae Infections / virology
- Time Factors
- Viral Load / immunology
Grant Funding
- R01 OD011095 / NIH HHS
- P30 EB011339 / NIBIB NIH HHS
- 8R01-OD011095-21 / NIH HHS
- P30-EB011339 / NIBIB NIH HHS
- HHSN272201000055C / NIAID NIH HHS
Conflict of Interest Statement
The authors have declared that no competing interests exist.
References
This article includes 67 references
- WHO. Fact Sheet No. 211. http://www.who.int/mediacentre/factsheets/fs211/en/. April 2009.
- Ronni T, Sareneva T, Pirhonen J, Julkunen I. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells.. J Immunol 1995 Mar 15;154(6):2764-74.
- Maines TR, Szretter KJ, Perrone L, Belser JA, Bright RA, Zeng H, Tumpey TM, Katz JM. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.. Immunol Rev 2008 Oct;225:68-84.
- Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melu00e9n K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.. Cytokine Growth Factor Rev 2001 Jun-Sep;12(2-3):171-80.
- Garcu00eda-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. The role of interferon in influenza virus tissue tropism.. J Virol 1998 Nov;72(11):8550-8.
- Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.. Nat Immunol 2006 May;7(5):517-23.
- Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.. Blood 2004 Jan 15;103(2):664-72.
- Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, Moretta A, Valiante NM, Parham P. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.. J Immunol 2007 Mar 1;178(5):2688-98.
- Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.. Nature 2001 Feb 22;409(6823):1055-60.
- Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30.. Eur J Immunol 2001 Sep;31(9):2680-9.
- Murphy K. 2012. 888 Janeway's Immunobiology: Garland Science.
- Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses.. Clin Microbiol Rev 2009 Apr;22(2):240-73, Table of Contents.
- Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, Mosmann TR, Perelson AS, Wu H, Topham DJ. Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.. J Virol 2010 Jul;84(13):6687-98.
- Kuiken T, Rimmelzwaan G, van Riel D, van Amerongen G, Baars M, Fouchier R, Osterhaus A. Avian H5N1 influenza in cats.. Science 2004 Oct 8;306(5694):241.
- Zitzow LA, Rowe T, Morken T, Shieh WJ, Zaki S, Katz JM. Pathogenesis of avian influenza A (H5N1) viruses in ferrets.. J Virol 2002 May;76(9):4420-9.
- Quinlivan M, Nelly M, Prendergast M, Breathnach C, Horohov D, Arkins S, Chiang YW, Chu HJ, Ng T, Cullinane A. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus.. Vaccine 2007 Oct 10;25(41):7056-64.
- Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD. Pathogenesis of influenza A (H5N1) virus infection in a primate model.. J Virol 2001 Jul;75(14):6687-91.
- Getto P, Kimmel M, Marciniak-Czochra A. Modelling and analysis of dynamics of viral infection of cells and of interferon resistance. J Math Anal Appl. 2008;344:821u2013850.
- Saenz RA, Quinlivan M, Elton D, Macrae S, Blunden AS, Mumford JA, Daly JM, Digard P, Cullinane A, Grenfell BT, McCauley JW, Wood JL, Gog JR. Dynamics of influenza virus infection and pathology.. J Virol 2010 Apr;84(8):3974-83.
- Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. Kinetics of influenza A virus infection in humans.. J Virol 2006 Aug;80(15):7590-9.
- Handel A, Longini IM Jr, Antia R. Towards a quantitative understanding of the within-host dynamics of influenza A infections.. J R Soc Interface 2010 Jan 6;7(42):35-47.
- Handel A, Longini IM Jr, Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.. PLoS Comput Biol 2007 Dec;3(12):e240.
- Smith AM, Adler FR, Perelson AS. An accurate two-phase approximate solution to an acute viral infection model.. J Math Biol 2010 May;60(5):711-26.
- Hancioglu B, Swigon D, Clermont G. A dynamical model of human immune response to influenza A virus infection.. J Theor Biol 2007 May 7;246(1):70-86.
- Bocharov GA, Romanyukha AA. Mathematical model of antiviral immune response. III. Influenza A virus infection.. J Theor Biol 1994 Apr 21;167(4):323-60.
- Beauchemin CA, McSharry JJ, Drusano GL, Nguyen JT, Went GT, Ribeiro RM, Perelson AS. Modeling amantadine treatment of influenza A virus in vitro.. J Theor Biol 2008 Sep 21;254(2):439-51.
- Lee HY, Topham DJ, Park SY, Hollenbaugh J, Treanor J, Mosmann TR, Jin X, Ward BM, Miao H, Holden-Wiltse J, Perelson AS, Zand M, Wu H. Simulation and prediction of the adaptive immune response to influenza A virus infection.. J Virol 2009 Jul;83(14):7151-65.
- Canini L, Carrat F. Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics.. J Virol 2011 Mar;85(6):2764-70.
- Smith AM, Perelson AS. Influenza A virus infection kinetics: quantitative data and models.. Wiley Interdiscip Rev Syst Biol Med 2011 Jul-Aug;3(4):429-45.
- Smith AM, Ribeiro RM. Modeling the viral dynamics of influenza A virus infection.. Crit Rev Immunol 2010;30(3):291-8.
- Beauchemin CA, Handel A. A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead.. BMC Public Health 2011 Feb 25;11 Suppl 1(Suppl 1):S7.
- Garcu00eda-Sastre A. Antiviral response in pandemic influenza viruses.. Emerg Infect Dis 2006 Jan;12(1):44-7.
- Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, Mack M, Kuziel WA, Corazza N, Brunner T, Seeger W, Lohmeyer J. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand.. J Exp Med 2008 Dec 22;205(13):3065-77.
- Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002 Dec 7;360(9348):1831-7.
- Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, Barber GN. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway.. J Virol 2000 Feb;74(3):1513-23.
- Mu00f6hler L, Flockerzi D, Sann H, Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture.. Biotechnol Bioeng 2005 Apr 5;90(1):46-58.
- Julkunen I, Melu00e9n K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. Inflammatory responses in influenza A virus infection.. Vaccine 2000 Dec 8;19 Suppl 1:S32-7.
- Dahari H, Major M, Zhang X, Mihalik K, Rice CM, Perelson AS, Feinstone SM, Neumann AU. Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.. Gastroenterology 2005 Apr;128(4):1056-66.
- Stone KC, Mercer RR, Gehr P, Stockstill B, Crapo JD. Allometric relationships of cell numbers and size in the mammalian lung.. Am J Respir Cell Mol Biol 1992 Feb;6(2):235-43.
- Suzuki Y, Ito T, Suzuki T, Holland RE Jr, Chambers TM, Kiso M, Ishida H, Kawaoka Y. Sialic acid species as a determinant of the host range of influenza A viruses.. J Virol 2000 Dec;74(24):11825-31.
- Thiu00e9baut R, Guedj J, Jacqmin-Gadda H, Chu00eane G, Trimoulet P, Neau D, Commenges D. Estimation of dynamical model parameters taking into account undetectable marker values.. BMC Med Res Methodol 2006 Aug 1;6:38.
- Helsel D. Much ado about next to nothing: incorporating nondetects in science.. Ann Occup Hyg 2010 Apr;54(3):257-62.
- Mumford JA, Hannant D, Jessett DM. Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols.. Equine Vet J 1990 Mar;22(2):93-8.
- Murphy BR, Chanock RM, Clements ML, Anthony WC, Sear AJ, Cisneros LA, Rennels MB, Miller EH, Black RE, Levine MM, Betts RF, Douglas RG Jr, Maassab HF, Cox NJ, Kendal AP. Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.. Infect Immun 1981 May;32(2):693-7.
- Murphy BR, Rennels MB, Douglas RG Jr, Betts RF, Couch RB, Cate TR Jr, Chanock RM, Kendal AP, Maassab HF, Suwanagool S, Sotman SB, Cisneros LA, Anthony WC, Nalin DR, Levine MM. Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.. Infect Immun 1980 Aug;29(2):348-55.
- Jao RL, Wheelock EF, Jackson GG. Production of interferon in volunteers infected with Asian influenza.. J Infect Dis 1970 Apr;121(4):419-26.
- Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.. J Immunol 2002 Oct 15;169(8):4279-87.
- Garcu00eda-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in du00e9tente .. Science 2006 May 12;312(5775):879-82.
- Lee CK, Rao DT, Gertner R, Gimeno R, Frey AB, Levy DE. Distinct requirements for IFNs and STAT1 in NK cell function.. J Immunol 2000 Oct 1;165(7):3571-7.
- Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines.. Annu Rev Immunol 1999;17:189-220.
- Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of age-related changes in natural killer cells during primary influenza infection in mice.. Mech Ageing Dev 2008 Apr;129(4):223-30.
- Stein-Streilein J, Guffee J. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection.. J Immunol 1986 Feb 15;136(4):1435-41.
- Stein-Streilein J, Guffee J, Fan W. Locally and systemically derived natural killer cells participate in defense against intranasally inoculated influenza virus.. Reg Immunol 1988 Sep-Oct;1(2):100-5.
- Denney L, Aitken C, Li CK, Wilson-Davies E, Kok WL, Clelland C, Rooney K, Young D, Dong T, McMichael AJ, Carman WF, Ho LP. Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection.. PLoS One 2010 May 18;5(5):e10675.
- Jost S, Quillay H, Reardon J, Peterson E, Simmons RP, Parry BA, Bryant NN, Binder WD, Altfeld M. Changes in cytokine levels and NK cell activation associated with influenza.. PLoS One 2011;6(9):e25060.
- Leung KN, Ada GL. Induction of natural killer cells during murine influenza virus infection.. Immunobiology 1981;160(3-4):352-66.
- Liu B, Mori I, Hossain MJ, Dong L, Takeda K, Kimura Y. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity.. J Gen Virol 2004 Feb;85(Pt 2):423-428.
- Monteiro JM, Harvey C, Trinchieri G. Role of interleukin-12 in primary influenza virus infection.. J Virol 1998 Jun;72(6):4825-31.
- Sareneva T, Matikainen S, Kurimoto M, Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells.. J Immunol 1998 Jun 15;160(12):6032-8.
- Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA.. J Exp Med 1999 Mar 1;189(5):821-9.
- Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJ, Brand A, Goulmy E. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells.. J Immunol 1999 Jul 1;163(1):57-61.
- Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.. Science 2004 Mar 5;303(5663):1529-31.
- Moltedo B, Lu00f3pez CB, Pazos M, Becker MI, Hermesh T, Moran TM. Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity.. J Immunol 2009 Sep 15;183(6):3569-73.
- Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T, Sealfon SC, Garcu00eda-Sastre A, Moran TM. Influenza virus evades innate and adaptive immunity via the NS1 protein.. J Virol 2006 Jul;80(13):6295-304.
- Kochs G, Garcu00eda-Sastre A, Martu00ednez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein.. J Virol 2007 Jul;81(13):7011-21.
- Mulder JHJ. Influenza. Groningen: Wolters-Noordhoff; 1972. 1972
- Taubenberger JK, Morens DM. The pathology of influenza virus infections.. Annu Rev Pathol 2008;3:499-522.
Citations
This article has been cited 124 times.- Farrell A, Phan T, Brooke CB, Koelle K, Ke R. Semi-infectious particles contribute substantially to influenza virus within-host dynamics when infection is dominated by spatial structure.. Virus Evol 2023;9(1):vead020.
- Perelson AS, Ribeiro RM, Phan T. An explanation for SARS-CoV-2 rebound after Paxlovid treatment.. medRxiv 2023 Jun 1;.
- Blanco-Rodru00edguez R, Ordou00f1ez-Jimu00e9nez F, Almocera AES, Chinney-Herrera G, Hernandez-Vargas E. Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19.. Math Biosci 2023 Jul;361:109011.
- Rao R, Musante CJ, Allen R. A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions.. NPJ Syst Biol Appl 2023 Apr 14;9(1):13.
- Vodovotz Y. Towards systems immunology of critical illness at scale: from single cell 'omics to digital twins.. Trends Immunol 2023 May;44(5):345-355.
- Korosec CS, Betti MI, Dick DW, Ooi HK, Moyles IR, Wahl LM, Heffernan JM. Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: Parameter estimates, identifiability, sensitivity and the eclipse phase profile.. J Theor Biol 2023 May 7;564:111449.
- Gazeau S, Deng X, Ooi HK, Mostefai F, Hussin J, Heffernan J, Jenner AL, Craig M. The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions.. Immunoinformatics (Amst) 2023 Mar;9:100021.
- Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics.. Nat Rev Microbiol 2023 Mar;21(3):147-161.
- Sandoni A, Schaffrath Rosario A, Michel J, Kuttig T, Wurm J, Damerow S, Iwanowski H, Finkel B, Schrick L, Buchholz U, Haas W, Varnaccia G, Kubisch U, Jordan S, Schienkiewitz A, Nitsche A, Loss J. SARS-CoV-2 viral clearance and viral load kinetics in young children (1-6 years) compared to adults: Results of a longitudinal study in Germany.. Front Pediatr 2022;10:989456.
- Jhutty SS, Boehme JD, Jeron A, Volckmar J, Schultz K, Schreiber J, Schughart K, Zhou K, Steinheimer J, Stu00f6cker H, Stegemann-Koniszewski S, Bruder D, Hernandez-Vargas EA. Predicting Influenza A Virus Infection in the Lung from Hematological Data with Machine Learning.. mSystems 2022 Dec 20;7(6):e0045922.
- Alamil M, Thu00e9baud G, Berthier K, Soubeyrand S. Characterizing viral within-host diversity in fast and non-equilibrium demo-genetic dynamics.. Front Microbiol 2022;13:983938.
- Boldova AE, Korobkin JD, Nechipurenko YD, Sveshnikova AN. Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19.. Int J Mol Sci 2022 Sep 26;23(19).
- Aristotelous AC, Chen A, Forest MG. A hybrid discrete-continuum model of immune responses to SARS-CoV-2 infection in the lung alveolar region, with a focus on interferon induced innate response.. J Theor Biol 2022 Dec 21;555:111293.
- Sanche S, Cassidy T, Chu P, Perelson AS, Ribeiro RM, Ke R. A simple model of COVID-19 explains disease severity and the effect of treatments.. Sci Rep 2022 Aug 20;12(1):14210.
- Darquenne C, Borojeni AAT, Colebank MJ, Forest MG, Madas BG, Tawhai M, Jiang Y. Aerosol Transport Modeling: The Key Link Between Lung Infections of Individuals and Populations.. Front Physiol 2022;13:923945.
- Chatterjee B, Singh Sandhu H, Dixit NM. Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms.. PLoS Pathog 2022 Jun;18(6):e1010630.
- Goyal A, Duke ER, Cardozo-Ojeda EF, Schiffer JT. Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir-treated rhesus macaques.. iScience 2022 Jun 17;25(6):104448.
- Ackerman EE, Weaver JJA, Shoemaker JE. Mathematical Modeling Finds Disparate Interferon Production Rates Drive Strain-Specific Immunodynamics during Deadly Influenza Infection.. Viruses 2022 Apr 27;14(5).
- Bull JJ, Antia R. Which 'imperfect vaccines' encourage the evolution of higher virulence?. Evol Med Public Health 2022;10(1):202-213.
- Ke R, Martinez PP, Smith RL, Gibson LL, Mirza A, Conte M, Gallagher N, Luo CH, Jarrett J, Zhou R, Conte A, Liu T, Farjo M, Walden KKO, Rendon G, Fields CJ, Wang L, Fredrickson R, Edmonson DC, Baughman ME, Chiu KK, Choi H, Scardina KR, Bradley S, Gloss SL, Reinhart C, Yedetore J, Quicksall J, Owens AN, Broach J, Barton B, Lazar P, Heetderks WJ, Robinson ML, Mostafa HH, Manabe YC, Pekosz A, McManus DD, Brooke CB. Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness.. Nat Microbiol 2022 May;7(5):640-652.
- Chen A, Wessler T, Daftari K, Hinton K, Boucher RC, Pickles R, Freeman R, Lai SK, Forest MG. Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection.. Biophys J 2022 May 3;121(9):1619-1631.
- Zhang L, Li R, Song G, Scholes GD, She ZS. Impairment of T cells' antiviral and anti-inflammation immunities may be critical to death from COVID-19.. R Soc Open Sci 2021 Dec;8(12):211606.
- Ke R, Zitzmann C, Ho DD, Ribeiro RM, Perelson AS. In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.. Proc Natl Acad Sci U S A 2021 Dec 7;118(49).
- Aponte-Serrano JO, Weaver JJA, Sego TJ, Glazier JA, Shoemaker JE. Multicellular spatial model of RNA virus replication and interferon responses reveals factors controlling plaque growth dynamics.. PLoS Comput Biol 2021 Oct;17(10):e1008874.
- Sohail A, Tunc S, Nutini A, Arif R. Furin and the adaptive mutation of SARS-COV2: a computational framework.. Model Earth Syst Environ 2022;8(2):2827-2836.
- Vaidya NK, Bloomquist A, Perelson AS. Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets.. Viruses 2021 Aug 18;13(8).
- Fatehi F, Bingham RJ, Dykeman EC, Stockley PG, Twarock R. Comparing antiviral strategies against COVID-19 via multiscale within-host modelling.. R Soc Open Sci 2021 Aug;8(8):210082.
- Ke R, Zitzmann C, Ho DD, Ribeiro RM, Perelson AS. In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.. medRxiv 2021 Jun 30;.
- Li K, Cao P, McCaw JM. Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.. Viruses 2021 May 7;13(5).
- Xie XT, Yitbarek A, Astill J, Singh S, Khan SU, Sharif S, Poljak Z, Greer AL. Within-host model of respiratory virus shedding and antibody response to H9N2 avian influenza virus vaccination and infection in chickens.. Infect Dis Model 2021;6:490-502.
- Gonu00e7alves A, Maisonnasse P, Donati F, Albert M, Behillil S, Contreras V, Naninck T, Marlin R, Solas C, Pizzorno A, Lemaitre J, Kahlaoui N, Terrier O, Ho Tsong Fang R, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Rosa Calatrava M, de Lamballerie X, Mentru00e9 F, Le Grand R, van der Werf S, Guedj J. SARS-CoV-2 viral dynamics in non-human primates.. PLoS Comput Biol 2021 Mar;17(3):e1008785.
- Czuppon P, Du00e9barre F, Gonu00e7alves A, Tenaillon O, Perelson AS, Guedj J, Blanquart F. Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.. PLoS Comput Biol 2021 Mar;17(3):e1008752.
- Michael Lavigne G, Russell H, Sherry B, Ke R. Autocrine and paracrine interferon signalling as 'ring vaccination' and 'contact tracing' strategies to suppress virus infection in a host.. Proc Biol Sci 2021 Feb 24;288(1945):20203002.
- Goyal A, Reeves DB, Cardozo-Ojeda EF, Schiffer JT, Mayer BT. Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events.. Elife 2021 Feb 23;10.
- Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina NA, Freyn AW, Snitselaar JL, Gonu00e7alves A, Caniels TG, Burger JA, Poniman M, Chesnais V, Diry S, Iershov A, Ronk AJ, Jangra S, Rathnasinghe R, Brouwer P, Bijl T, van Schooten J, Brinkkemper M, Liu H, Yuan M, Mire CE, van Breemen MJ, Contreras V, Naninck T, Lemau00eetre J, Kahlaoui N, Relouzat F, Chapon C, Ho Tsong Fang R, McDanal C, Osei-Twum M, St-Amant N, Gagnon L, Montefiori DC, Wilson IA, Ginoux E, de Bree GJ, Garcu00eda-Sastre A, Schotsaert M, Coughlan L, Bukreyev A, van der Werf S, Guedj J, Sanders RW, van Gils MJ, Le Grand R. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.. Res Sq 2021 Feb 15;.
- Best K, Barouch DH, Guedj J, Ribeiro RM, Perelson AS. Zika virus dynamics: Effects of inoculum dose, the innate immune response and viral interference.. PLoS Comput Biol 2021 Jan;17(1):e1008564.
- Perelson AS, Ke R. Mechanistic Modeling of SARS-CoV-2 and Other Infectious Diseases and the Effects of Therapeutics.. Clin Pharmacol Ther 2021 Apr;109(4):829-840.
- Peter S, Dittrich P, Ibrahim B. Structure and Hierarchy of SARS-CoV-2 Infection Dynamics Models Revealed by Reaction Network Analysis.. Viruses 2020 Dec 23;13(1).
- Metcalf CJE, Grenfell BT, Graham AL. Disentangling the dynamical underpinnings of differences in SARS-CoV-2 pathology using within-host ecological models.. PLoS Pathog 2020 Dec;16(12):e1009105.
- Dai W, Rao R, Sher A, Tania N, Musante CJ, Allen R. A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development.. CPT Pharmacometrics Syst Pharmacol 2021 Jan;10(1):18-29.
- Jaiswal S, Kumar M, Mandeep, Sunita, Singh Y, Shukla P. Systems Biology Approaches for Therapeutics Development Against COVID-19.. Front Cell Infect Microbiol 2020;10:560240.
- Morris DH, Petrova VN, Rossine FW, Parker E, Grenfell BT, Neher RA, Levin SA, Russell CA. Asynchrony between virus diversity and antibody selection limits influenza virus evolution.. Elife 2020 Nov 11;9.
- Goyal A, Cardozo-Ojeda EF, Schiffer JT. Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response.. Sci Adv 2020 Nov;6(47).
- Goyal A, Reeves DB, Cardozo-Ojeda EF, Schiffer JT, Mayer BT. Wrong person, place and time: viral load and contact network structure predict SARS-CoV-2 transmission and super-spreading events.. medRxiv 2020 Sep 28;.
- Hernandez-Vargas EA, Velasco-Hernandez JX. In-host Mathematical Modelling of COVID-19 in Humans.. Annu Rev Control 2020;50:448-456.
- Wang S, Pan Y, Wang Q, Miao H, Brown AN, Rong L. Modeling the viral dynamics of SARS-CoV-2 infection.. Math Biosci 2020 Oct;328:108438.
- Canini L, Holzer B, Morgan S, Dinie Hemmink J, Clark B, Woolhouse MEJ, Tchilian E, Charleston B. Timelines of infection and transmission dynamics of H1N1pdm09 in swine.. PLoS Pathog 2020 Jul;16(7):e1008628.
- Gonu00e7alves A, Bertrand J, Ke R, Comets E, de Lamballerie X, Malvy D, Pizzorno A, Terrier O, Rosa Calatrava M, Mentru00e9 F, Smith P, Perelson AS, Guedj J. Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.. CPT Pharmacometrics Syst Pharmacol 2020 Sep;9(9):509-514.
- Nicholson LB, Blyuss KB, Fatehi F. Quantifying the Role of Stochasticity in the Development of Autoimmune Disease.. Cells 2020 Apr 2;9(4).
- Madelain V, Mentru00e9 F, Baize S, Anglaret X, Laouu00e9nan C, Oestereich L, Nguyen THT, Malvy D, Piorkowski G, Graw F, Gu00fcnther S, Raoul H, de Lamballerie X, Guedj J. Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.. CPT Pharmacometrics Syst Pharmacol 2020 May;9(5):258-271.
- Gonu00e7alves A, Mentru00e9 F, Lemenuel-Diot A, Guedj J. Model Averaging in Viral Dynamic Models.. AAPS J 2020 Feb 13;22(2):48.
- Brook CE, Boots M, Chandran K, Dobson AP, Drosten C, Graham AL, Grenfell BT, Mu00fcller MA, Ng M, Wang LF, van Leeuwen A. Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence.. Elife 2020 Feb 3;9.
- Haghnegahdar A, Zhao J, Feng Y. Lung Aerosol Dynamics of Airborne Influenza A Virus-Laden Droplets and the Resultant Immune System Responses: An In Silico Study.. J Aerosol Sci 2019 Aug;134:34-55.
- Wethington D, Harder O, Uppulury K, Stewart WCL, Chen P, King T, Reynolds SD, Perelson AS, Peeples ME, Niewiesk S, Das J. Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats.. J R Soc Interface 2019 Nov 29;16(160):20190389.
- Sharma-Chawla N, Stegemann-Koniszewski S, Christen H, Boehme JD, Kershaw O, Schreiber J, Guzmu00e1n CA, Bruder D, Hernandez-Vargas EA. In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection.. Front Immunol 2019;10:1864.
- Baral S, Antia R, Dixit NM. A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections.. Proc Natl Acad Sci U S A 2019 Aug 27;116(35):17393-17398.
- Huang Y, Dai H, Ke R. Principles of Effective and Robust Innate Immune Response to Viral Infections: A Multiplex Network Analysis.. Front Immunol 2019;10:1736.
- Bull JJ, Nuismer SL, Antia R. Recombinant vector vaccine evolution.. PLoS Comput Biol 2019 Jul;15(7):e1006857.
- Koelle K, Farrell AP, Brooke CB, Ke R. Within-host infectious disease models accommodating cellular coinfection, with an application to influenza.. Virus Evol 2019 Jul;5(2):vez018.
- Moses ME, Cannon JL, Gordon DM, Forrest S. Distributed Adaptive Search in T Cells: Lessons From Ants.. Front Immunol 2019;10:1357.
- Peter S, Hu00f6lzer M, Lamkiewicz K, di Fenizio PS, Al Hwaeer H, Marz M, Schuster S, Dittrich P, Ibrahim B. Structure and Hierarchy of Influenza Virus Models Revealed by Reaction Network Analysis.. Viruses 2019 May 16;11(5).
- Zhao L, Abbasi AB, Illingworth CJR. Mutational load causes stochastic evolutionary outcomes in acute RNA viral infection.. Virus Evol 2019 Jan;5(1):vez008.
- Reinharz V, Churkin A, Dahari H, Barash D. A Robust and Efficient Numerical Method for RNA-Mediated Viral Dynamics.. Front Appl Math Stat 2017 Oct;3.
- Saad-Roy CM, McDermott AB, Grenfell BT. Dynamic Perspectives on the Search for a Universal Influenza Vaccine.. J Infect Dis 2019 Apr 8;219(Suppl_1):S46-S56.
- Go N, Touzeau S, Islam Z, Belloc C, Doeschl-Wilson A. How to prevent viremia rebound? Evidence from a PRRSv data-supported model of immune response.. BMC Syst Biol 2019 Jan 29;13(1):15.
- Yan AWC, Zaloumis SG, Simpson JA, McCaw JM. Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection.. PLoS Comput Biol 2019 Jan;15(1):e1006568.
- Morris SE, Yates AJ, de Swart RL, de Vries RD, Mina MJ, Nelson AN, Lin WW, Kouyos RD, Griffin DE, Grenfell BT. Modeling the measles paradox reveals the importance of cellular immunity in regulating viral clearance.. PLoS Pathog 2018 Dec;14(12):e1007493.
- Gallagher ME, Brooke CB, Ke R, Koelle K. Causes and Consequences of Spatial Within-Host Viral Spread.. Viruses 2018 Nov 13;10(11).
- Madelain V, Baize S, Jacquot F, Reynard S, Fizet A, Barron S, Solas C, Lacarelle B, Carbonnelle C, Mentru00e9 F, Raoul H, de Lamballerie X, Guedj J. Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.. Nat Commun 2018 Oct 1;9(1):4013.
- Handel A, Li Y, McKay B, Pawelek KA, Zarnitsyna V, Antia R. Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design.. PLoS Comput Biol 2018 Oct;14(10):e1006505.
- Leviyang S, Griva I. Investigating Functional Roles for Positive Feedback and Cellular Heterogeneity in the Type I Interferon Response to Viral Infection.. Viruses 2018 Sep 21;10(10).
- Best K, Perelson AS. Mathematical modeling of within-host Zika virus dynamics.. Immunol Rev 2018 Sep;285(1):81-96.
- Smith AM. Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling.. Immunol Rev 2018 Sep;285(1):97-112.
- Zitzmann C, Kaderali L. Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling.. Front Microbiol 2018;9:1546.
- Smith AP, Moquin DJ, Bernhauerova V, Smith AM. Influenza Virus Infection Model With Density Dependence Supports Biphasic Viral Decay.. Front Microbiol 2018;9:1554.
- Ciupe SM, Heffernan JM. In-host modeling.. Infect Dis Model 2017 May;2(2):188-202.
- Perera SD, Perera SSN. Simulation Model for Dynamics of Dengue with Innate and Humoral Immune Responses.. Comput Math Methods Med 2018;2018:8798057.
- Hauck NC, Kirpach J, Kiefer C, Farinelle S, Maucourant S, Morris SA, Rosenberg W, He FQ, Muller CP, Lu IN. Applying Unique Molecular Identifiers in Next Generation Sequencing Reveals a Constrained Viral Quasispecies Evolution under Cross-Reactive Antibody Pressure Targeting Long Alpha Helix of Hemagglutinin.. Viruses 2018 Mar 25;10(4).
- Reinharz V, Dahari H, Barash D. Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.. Math Biosci 2018 Jun;300:1-13.
- Goyal A, Ribeiro RM, Perelson AS. The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans.. Viruses 2017 Nov 18;9(11).
- Moore J, Ahmed H, Jia J, Akondy R, Ahmed R, Antia R. What Controls the Acute Viral Infection Following Yellow Fever Vaccination?. Bull Math Biol 2018 Jan;80(1):46-63.
- Pawelek KA, Salmeron C, Del Valle S. Connecting within and between-hosts dynamics in the influenza infection-staged epidemiological models with behavior change.. J Coupled Syst Multiscale Dyn 2015 Sep;3(3):233-243.
- Cao P, McCaw JM. The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment.. Viruses 2017 Jul 26;9(8).
- Dobrovolny HM, Beauchemin CAA. Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.. PLoS One 2017;12(7):e0180582.
- Aid M, Abbink P, Larocca RA, Boyd M, Nityanandam R, Nanayakkara O, Martinot AJ, Moseley ET, Blass E, Borducchi EN, Chandrashekar A, Brinkman AL, Molloy K, Jetton D, Tartaglia LJ, Liu J, Best K, Perelson AS, De La Barrera RA, Lewis MG, Barouch DH. Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys.. Cell 2017 May 4;169(4):610-620.e14.
- Cao P, Wang Z, Yan AW, McVernon J, Xu J, Heffernan JM, Kedzierska K, McCaw JM. On the Role of CD8(+) T Cells in Determining Recovery Time from Influenza Virus Infection.. Front Immunol 2016;7:611.
- Nguyen VK, Klawonn F, Mikolajczyk R, Hernandez-Vargas EA. Analysis of Practical Identifiability of a Viral Infection Model.. PLoS One 2016;11(12):e0167568.
- Canini L, Woolhouse ME, Maines TR, Carrat F. Heterogeneous shedding of influenza by human subjects and its implications for epidemiology and control.. Sci Rep 2016 Dec 14;6:38749.
- Duvigneau S, Sharma-Chawla N, Boianelli A, Stegemann-Koniszewski S, Nguyen VK, Bruder D, Hernandez-Vargas EA. Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection.. Sci Rep 2016 Nov 22;6:37045.
- Peck KM, Chan CH, Tanaka MM. Connecting within-host dynamics to the rate of viral molecular evolution.. Virus Evol 2015;1(1):vev013.
- Boianelli A, Sharma-Chawla N, Bruder D, Hernandez-Vargas EA. Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.. Front Cell Infect Microbiol 2016;6:60.
- Zarnitsyna VI, Lavine J, Ellebedy A, Ahmed R, Antia R. Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza.. PLoS Pathog 2016 Jun;12(6):e1005692.
- Hadjichrysanthou C, Cauu00ebt E, Lawrence E, Vegvari C, de Wolf F, Anderson RM. Understanding the within-host dynamics of influenza A virus: from theory to clinical implications.. J R Soc Interface 2016 Jun;13(119).
- Zarnitsyna VI, Handel A, McMaster SR, Hayward SL, Kohlmeier JE, Antia R. Mathematical Model Reveals the Role of Memory CD8 T Cell Populations in Recall Responses to Influenza.. Front Immunol 2016;7:165.
- Banerjee S, Guedj J, Ribeiro RM, Moses M, Perelson AS. Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection.. J R Soc Interface 2016 Apr;13(117).
- Browne EP, Letham B, Rudin C. A Computational Model of Inhibition of HIV-1 by Interferon-Alpha.. PLoS One 2016;11(3):e0152316.
- Levin D, Forrest S, Banerjee S, Clay C, Cannon J, Moses M, Koster F. A spatial model of the efficiency of T cell search in the influenza-infected lung.. J Theor Biol 2016 Jun 7;398:52-63.
- Pawelek KA, Dor D Jr, Salmeron C, Handel A. Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of Macrophages.. PLoS One 2016;11(2):e0150568.
- Yan AW, Cao P, McCaw JM. On the extinction probability in models of within-host infection: the role of latency and immunity.. J Math Biol 2016 Oct;73(4):787-813.
- Schmid B, Rinas M, Ruggieri A, Acosta EG, Bartenschlager M, Reuter A, Fischl W, Harder N, Bergeest JP, Flossdorf M, Rohr K, Hu00f6fer T, Bartenschlager R. Live Cell Analysis and Mathematical Modeling Identify Determinants of Attenuation of Dengue Virus 2'-O-Methylation Mutant.. PLoS Pathog 2015 Dec;11(12):e1005345.
- Boianelli A, Nguyen VK, Ebensen T, Schulze K, Wilk E, Sharma N, Stegemann-Koniszewski S, Bruder D, Toapanta FR, Guzmu00e1n CA, Meyer-Hermann M, Hernandez-Vargas EA. Modeling Influenza Virus Infection: A Roadmap for Influenza Research.. Viruses 2015 Oct 12;7(10):5274-304.
- Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, Laurie KL, McCaw JM. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.. PLoS Comput Biol 2015 Aug;11(8):e1004334.
- Perelson AS, Guedj J. Modelling hepatitis C therapy--predicting effects of treatment.. Nat Rev Gastroenterol Hepatol 2015 Aug;12(8):437-45.
- Nguyen VK, Binder SC, Boianelli A, Meyer-Hermann M, Hernandez-Vargas EA. Ebola virus infection modeling and identifiability problems.. Front Microbiol 2015;6:257.
- Price I, Mochan-Keef ED, Swigon D, Ermentrout GB, Lukens S, Toapanta FR, Ross TM, Clermont G. The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study.. J Theor Biol 2015 Jun 7;374:83-93.
- Ben-Shachar R, Koelle K. Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections.. J R Soc Interface 2015 Feb 6;12(103).
- Pawelek KA, Niehaus P, Salmeron C, Hager EJ, Hunt GJ. Modeling dynamics of culex pipiens complex populations and assessing abatement strategies for West Nile Virus.. PLoS One 2014;9(9):e108452.
- Li Z, Zhou H, Lu Y, Colatsky T. A Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic Modeling.. CPT Pharmacometrics Syst Pharmacol 2014 Sep 10;3(9):e135.
- Illingworth CJ, Fischer A, Mustonen V. Identifying selection in the within-host evolution of influenza using viral sequence data.. PLoS Comput Biol 2014 Jul;10(7):e1003755.
- Smith AM, McCullers JA. Secondary bacterial infections in influenza virus infection pathogenesis.. Curr Top Microbiol Immunol 2014;385:327-56.
- Canini L, Perelson AS. Viral kinetic modeling: state of the art.. J Pharmacokinet Pharmacodyn 2014 Oct;41(5):431-43.
- Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, Ross TM, Guzmu00e1n CA, Perelson AS, Meyer-Hermann M. Effects of aging on influenza virus infection dynamics.. J Virol 2014 Apr;88(8):4123-31.
- Islam ZU, Bishop SC, Savill NJ, Rowland RR, Lunney JK, Trible B, Doeschl-Wilson AB. Quantitative analysis of porcine reproductive and respiratory syndrome (PRRS) viremia profiles from experimental infection: a statistical modelling approach.. PLoS One 2013;8(12):e83567.
- Heldt FS, Frensing T, Pflugmacher A, Gru00f6pler R, Peschel B, Reichl U. Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals.. PLoS Comput Biol 2013;9(11):e1003372.
- Woo HJ, Reifman J. Quantitative modeling of virus evolutionary dynamics and adaptation in serial passages using empirically inferred fitness landscapes.. J Virol 2014 Jan;88(2):1039-50.
- Jin S, Zou X. Construction of the influenza A virus infection-induced cell-specific inflammatory regulatory network based on mutual information and optimization.. BMC Syst Biol 2013 Oct 20;7:105.
- Petrie SM, Guarnaccia T, Laurie KL, Hurt AC, McVernon J, McCaw JM. Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.. PLoS One 2013;8(5):e64098.
- Daly JM, Newton JR, Wood JL, Park AW. What can mathematical models bring to the control of equine influenza?. Equine Vet J 2013 Nov;45(6):784-8.
- Murillo LN, Murillo MS, Perelson AS. Towards multiscale modeling of influenza infection.. J Theor Biol 2013 Sep 7;332:267-90.
- Handel A, Brown J, Stallknecht D, Rohani P. A multi-scale analysis of influenza A virus fitness trade-offs due to temperature-dependent virus persistence.. PLoS Comput Biol 2013;9(3):e1002989.
- Dobrovolny HM, Reddy MB, Kamal MA, Rayner CR, Beauchemin CA. Assessing mathematical models of influenza infections using features of the immune response.. PLoS One 2013;8(2):e57088.
- Arazi A, Pendergraft WF 3rd, Ribeiro RM, Perelson AS, Hacohen N. Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.. Semin Immunol 2013 Oct 31;25(3):193-200.
- Zhang J, Lipton HL, Perelson AS, Dahari H. Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.. J Virol 2013 Apr;87(7):4052-9.
- Roberts KL, Shelton H, Stilwell P, Barclay WS. Transmission of a 2009 H1N1 pandemic influenza virus occurs before fever is detected, in the ferret model.. PLoS One 2012;7(8):e43303.